MK Raheja, PhD, (l) and Brenton Taylor.

MENLO PARK, Calif.—Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company, has announced the appointment of MK Raheja, PhD as its executive vice president, research and development, and Brenton Taylor as its executive vice president, operations, effective November 4, 2024. The company also announced that Sam Park, its chief operating officer, who oversaw both R&D and operations, will be retiring from his role, effective November 15, 2024, and will remain available to the company as a consultant.

“We are very excited to have both MK and Brenton join Sight Sciences as we continue to transform treatment paradigms with disruptive new eyecare technology, and predictably scale our operations and drive our innovation pipeline," said Paul Badawi, founder and chief executive officer of Sight Sciences. "We believe their unique skill sets, with both MK’s ophthalmic innovation leadership experience at several industry-leading ophthalmic organizations and Brenton’s broad development and operational experience, directly align with our vision of the future of eyecare."

Badawi continued, “We are confident the additions of MK and Brenton will further enhance the capabilities of our strong executive team and set us up for continued success at scale over the coming years. We are looking forward to them partnering to lead the separate R&D and operations organizations with dedicated resources to advance our strategic plans and ensure we have the appropriate infrastructure to support profitable growth over the coming years."

 
He added, “I also want to acknowledge Sam’s many contributions to Sight Sciences over the last four years. He has been instrumental in helping to grow Sight Sciences by contributing meaningfully to our reliable supply chain, cost efficiencies, and the development of multiple innovations in surgical glaucoma and dry eye. We thank Sam and wish him the very best in his retirement.”

Dr. Raheja has more than 35 years of experience in ophthalmology medical device innovation, overseeing global ophthalmic R&D organizations responsible for bringing more than 70 ophthalmic innovations to market. Over the past 18 months, Dr. Raheja has been advising emerging ophthalmic companies and not-for-profit entrepreneurial institutions. His most recent corporate roles include head of surgical vision R&D at Johnson & Johnson Vision and global head of corneal & cataract R&D at Abbott Medical Optics, spanning a 14-year period that ended in April 2023.

According to the announcement, Taylor has nearly 25 years of experience in medical and energy technology development and operations, overseeing innovation, product development and manufacturing. He most recently served as chief executive officer at NEXT Energy Technologies, a pioneer in organic photovoltaic (OPV) technology, where he initially joined as executive vice president of engineering in 2021.